← Back to Videos
This content has been automatically translated. View original in Arabic
To help you identify the factors for safe fasting, which we mentioned in previous episodes, remember these six pillars:
A final note: It is preferable to avoid the "sulfonylureas" group of medications during Ramadan due to the possibility of causing a sharp drop in blood sugar. If the patient continues with them, it is advisable to avoid the older medications in this group such as "glibenclamide" (Glibenclamide), commercially known as "Daonil," and to use newer medications such as "Amaryl."
In conclusion, we ask Allah, the Most High, for us and for you a safe and accepted fast, and a blessed Ramadan. Peace be upon you and the mercy of Allah and His blessings.